2013
DOI: 10.2105/ajph.2013.301232
|View full text |Cite
|
Sign up to set email alerts
|

Smokers With Behavioral Health Comorbidity Should Be Designated a Tobacco Use Disparity Group

Abstract: Smokers with co-occurring mental illness or substance use disorders are not listed as a disparity group or priority population by most national public health or tobacco control groups. Smokers with behavioral health comorbidity fulfill the criteria commonly used to designate other groups including targeted marketing by the tobacco industry, greater smoking prevalence rates, increased economic and health burden from tobacco, less access to treatment services and longer durations of smoking with less cessation. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
110
1
3

Year Published

2013
2013
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 127 publications
(120 citation statements)
references
References 62 publications
5
110
1
3
Order By: Relevance
“…21 The documented intersection of tobacco and mental illness has led to calls for recognition of smokers with co-occurring psychiatric disorders as a disparity group in need of national surveillance, research, and treatment. 22,23 The 2008 update of the U.S. Clinical Practice Guidelines for tobacco cessation was informed by nearly 8,800 research articles; yet fewer than two-dozen trials have been conducted with smokers with mental illness, of which only one was conducted with adolescents. Brown et al 24 recruited 191 smokers aged 13-17 years from an inpatient psychiatry unit and evaluated a motivational-interviewing intervention combined with NRT patch relative to usual care.…”
Section: Gender Differences In a Randomized Controlled Trial Treatingmentioning
confidence: 99%
“…21 The documented intersection of tobacco and mental illness has led to calls for recognition of smokers with co-occurring psychiatric disorders as a disparity group in need of national surveillance, research, and treatment. 22,23 The 2008 update of the U.S. Clinical Practice Guidelines for tobacco cessation was informed by nearly 8,800 research articles; yet fewer than two-dozen trials have been conducted with smokers with mental illness, of which only one was conducted with adolescents. Brown et al 24 recruited 191 smokers aged 13-17 years from an inpatient psychiatry unit and evaluated a motivational-interviewing intervention combined with NRT patch relative to usual care.…”
Section: Gender Differences In a Randomized Controlled Trial Treatingmentioning
confidence: 99%
“…Lack of health insurance and reduced access to affordable smoking cessation treatments potentially contribute to elevated smoking prevalence among persons with BHCs (19,20). Tobacco cessation treatments, including brief advice to quit, behavioral counseling, and pharmacotherapy, are evidence based and cost-effective, and they decrease the likelihood of tobacco relapses (21).…”
mentioning
confidence: 99%
“…21 Some experts in the United States have argued strongly that tobacco use by people with a mental illness continues to be insufficiently prioritized for policy and program attention, and that this population group should be more strongly identified as a "tobacco use disparity group," particularly at a national level. 56 While there was no difference in the amount of intervention research over time, there was some indication of progression in terms of the level of evidence provided by the intervention research undertaken, with a modest rise in the number and proportion of systematic reviews/meta-analyses and RCTs between 1993-1995 and 2013-2015. The increasing tendency toward synthesizing research findings through systematic review/ meta-analyses perhaps also suggests an increased acknowledgement of the importance of this public health issue.…”
Section: Discussionmentioning
confidence: 99%